Last update :
19/11/2024
Anticancer drug   Ipilimumab  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Yervoy Argentina, Australia, Belgium, Canada, Chile, Colombia, Denmark, France, Germany, Great Britain, Iceland, Ireland, Italy, Mexico, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden, Switzerland, Turkey, United States of America
Stability in solutions   injection   Stability in solutions : Ipilimumab     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 1 >> 4 mg/ml 2-8°C Protect from light
24 Hour
3352
Manufacturer's stability data

Glass NaCl 0,9% or Glucose 5% 1 >> 4 mg/ml 25°C Not specified
24 Hour
3352
Manufacturer's stability data

partially used vials None 5 mg/ml 25°C Protect from light
28 Day
3850
Level of evidence A+

partially used vials None 5 mg/ml 4°C Protect from light
28 Day
3850
Level of evidence A+

Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 >> 4 mg/ml 2-8°C Protect from light
24 Hour
3352
Manufacturer's stability data

Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 >> 4 mg/ml 25°C Not specified
24 Hour
3352
Manufacturer's stability data

Polyolefine NaCl 0,9% or Glucose 5% 1 >> 4 mg/ml 2-8°C Protect from light
24 Hour
3352
Manufacturer's stability data

Polyolefine NaCl 0,9% or Glucose 5% 1 >> 4 mg/ml 25°C Not specified
24 Hour
3352
Manufacturer's stability data

Polyolefine Sodium chloride 0,9% 2 mg/ml 22°C Protect from light
30 Day
3446
Level of evidence B+

Polyolefine Sodium chloride 0,9% 2 mg/ml 4°C Protect from light
30 Day
3446
Level of evidence B+


  Mentions Légales